A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosisRoberta D’Ambrosio, Pierre Bédossa, Alessio Aghemo et al.|Hepatology|2012Cited by 404
High rates of 30-day mortality in patients with cirrhosis and COVID-19Massimo Iavarone, Pietro Lampertico, Angiola Spinetti et al.|Journal of Hepatology|2020Cited by 392
Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis CMaria Grazia Rumi, Massimo Colombo, Alessio Aghemo et al.|Gastroenterology|2009Cited by 199
The diagnostic accuracy of Fibroscan® for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological responseRoberta D’Ambrosio, Massimo Colombo, Alessio Aghemo et al.|Journal of Hepatology|2013Cited by 147
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis CRoberta D’Ambrosio, S. Fagiuoli, L. Pasulo et al.|Journal of Hepatology|2018Cited by 132